#Injective's Weekly Update: January 2nd - 7th, 2024
*Volan Mainnet Upgrade:
The week kicked off with a resounding vote of confidence in the Injective Volan Mainnet Upgrade. With over 18 million #
$INJ tokens cast and a near-unanimous 99.9% approval rate, the community greenlit the upgrade, paving the way for exciting innovations like:
–New RWA module: Bringing real-world assets onto the Injective platform expands possibilities for decentralized finance.
–Expanded burn mechanic: Increased token burning fosters deflationary pressure, potentially boosting #INJ's long-term value.
–IBC Cross-Chain Expansion: Interoperability with other blockchains strengthens Injective's position in the broader DeFi ecosystem.
*Hydro Prepares to Make Waves:
Get ready for Hydro, the ultimate liquid staking platform, set to launch mainnet on January 31st, 2024. The team at @hydro_fi has laid out a clear roadmap:
–Mainnet Launch: January 31st.
–Public Sale: February 2024 marks your chance to acquire tokens.
–TGE (Token Generation Event): March 2024.
*Quants Reign Supreme:
#injective Quants, a unique NFT collection and meme token that burns
$INJ , captured the top spot in the Mitofinance launchpad competition based on community voting.
*Trust
#Wallet Joins the Ranks:
The popular Trust wallet, boasting over 60 million users, has officially become a validator on Injective. This is a significant development as it bolsters the network's security and decentralization. Stake your tokens and delegate to Trust wallet directly from within the platform.
*Milestones Achieved, Growth Continues:
#injective. surpassed 400 million on-chain transactions and reached over 300,000 active wallet addresses, demonstrating robust user engagement and network activity.
*Dojo pool is live and now tradable on coinhall with an impressive $3.9 million TVL and $4.32 million 7-day volume, further expanding its reach and accessibility.
Last but not least, Helix, the cross-chain margin exchange on Injective, achieved a remarkable 16 billion cumulative TVL.
For more info, visit @ Injective.com